Skip to main content
. 2025 May 8;16:1486197. doi: 10.3389/fendo.2025.1486197

Table 5.

Associations of PDX1 with adverse pregnancy outcomes.

Items Model 1 Model 2
OR 95%CI P OR 95%CI P
Pre-eclampsia
 Per 1 pg/mL 0.967 0.928-1.008 0.110 0.971 0.932-1.012 0.160
 PDX1<131pg/mL Reference Reference
 PDX1≥131pg/mL 0.319 0.063-1.613 0.167 0.320 0.055-1.845 0.202
Fetal growth restriction
 Per 1 pg/mL 0.994 0.968-1.021 0.646 0.990 0.962-1.019 0.496
 PDX1<131pg/mL Reference Reference
 PDX1≥131pg/mL 1.143 0.400-3.262 0.803 1.020 0.348-2.988 0.971
Preterm birth
 Per 1 pg/mL 0.974 0.948-1.001 0.059 0.971 0.942-1.000 0.049
 PDX1<131pg/mL Reference Reference
 PDX1≥131pg/mL 0.353 0.122-1.026 0.056 0.326 0.104-1.021 0.054
Macrosomia
 Per 1 pg/mL 0.951 0.921-0.982 0.002 0.942 0.909-0.977 0.001
 PDX1<131pg/mL Reference Reference
 PDX1≥131pg/mL 0.280 0.089-0.887 0.030 0.249 0.076-0.811 0.021
Neonatal respiratory distress syndrome
 Per 1 pg/mL 1.002 0.965-1.039 0.931 1.007 0.968-1.048 0.712
 PDX1<131pg/mL Reference Reference
 PDX1≥131pg/mL 0.737 0.161-3.367 0.694 0.811 0.165-3.997 0.797
Composite adverse pregnancy outcomes
 Per 1 pg/mL 0.974 0.958-0.991 0.004 0.974 0.965-0.991 0.004
 PDX1<131pg/mL Reference Reference
 PDX1≥131pg/mL 0.487 0.258-0.920 0.027 0.496 0.256-0.960 0.037

Model 1: not adjusted; Model 2: adjusted for age, preconception BMI, family history of diabetes, smoking exposure, alcohol consumption, and GDM.